[Corrigendum] lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR-106a-5p-mediated P38 MAPK signaling
Ting Tang, Ling-Xing Wang, Mei-Li Yang, Rong-Mou Zhang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer-related molecular mechanisms research
Mol Med Rep 22: 4857–4867, 2020; DOI: 10.3892/mmr.2020.11542
Subsequently to the publication of this paper, an interested reader drew to the authors’ attention that the control β-actin western blots shown in Fig. 4D on p. 4864 were strikingly similar to control blots that had appeared in another paper by the same group published previously in the journal Biochemical and Biophysical Research Communications.
The authors have re-examined their original data, and realize that this figure was assembled incorrectly. The revised version of Fig. 4, now featuring the correct β-actin western blots in Fig. 4D, is shown on the next page. The authors sincerely apologize for the error introduced during the preparation of this figure, although they confirm that this did not grossly affect either the results or the conclusions reported in this study. They also thank the Editor of Molecular Medicine Reports for allowing them the opportunity to publish a Corrigendum, and regret any inconvenience caused to the readership.